DHODH-话题@MedSci

#DHODH#

5篇内容 | 1129人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2177945, encodeId=bb5921e794537, content=<a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三阴性乳腺癌#</a> <a href='/topic/show?id=8ef35910fe' target=_blank style='color:#2F92EE;'>#DHODH#</a>, objectTitle=中国药科大学姜虎林教授《Biomaterials》：一种具有GSH消耗和DHODH抑制功能的白蛋白纳米药物有效治疗三阴性乳腺癌, objectType=article, longId=807293, objectId=fa7f80e293a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017217327_4754896.png, objectUrl=/article/show_article.do?id=fa7f80e293a4, replyNumber=0, likeNumber=74, createdTime=2023-12-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fa7f80e293a4, moduleTitle=中国药科大学姜虎林教授《Biomaterials》：一种具有GSH消耗和DHODH抑制功能的白蛋白纳米药物有效治疗三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa7f80e293a4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1944016, encodeId=1a4c194401698, content=<a href='/topic/show?id=8ef35910fe' target=_blank style='color:#2F92EE;'>#DHODH#</a>, objectTitle=Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据, objectType=article, longId=724127, objectId=b5ebe2412785, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ebe2412785, replyNumber=0, likeNumber=100, createdTime=2022-12-18, rootId=0, userName=tongyongming, userId=76d3356, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ebe2412785, moduleTitle=Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ebe2412785)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944015, encodeId=d5ca194401598, content=<a href='/topic/show?id=8ef35910fe' target=_blank style='color:#2F92EE;'>#DHODH#</a>, objectTitle=华东理工大学拟以1.5亿元受让DHODH抑制剂相关专利给海南海药, objectType=article, longId=205579, objectId=bc002055e98a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc002055e98a, replyNumber=0, likeNumber=74, createdTime=2021-05-29, rootId=0, userName=tongyongming, userId=76d3356, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc002055e98a, moduleTitle=华东理工大学拟以1.5亿元受让DHODH抑制剂相关专利给海南海药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc002055e98a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944013, encodeId=656b19440139d, content=<a href='/topic/show?id=8ef35910fe' target=_blank style='color:#2F92EE;'>#DHODH#</a>, objectTitle=Protein Cell：|李洪林/徐可团队发现靶向宿主DHODH的强效抗新冠病毒候选和临床已有药物, objectType=article, longId=199135, objectId=dd5a1991357c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd5a1991357c, replyNumber=0, likeNumber=88, createdTime=2021-07-06, rootId=0, userName=tongyongming, userId=76d3356, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd5a1991357c, moduleTitle=Protein Cell：|李洪林/徐可团队发现靶向宿主DHODH的强效抗新冠病毒候选和临床已有药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd5a1991357c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944014, encodeId=a5241944014d5, content=<a href='/topic/show?id=8ef35910fe' target=_blank style='color:#2F92EE;'>#DHODH#</a>, objectTitle=Cell Death Dis：高表达水平DHODH介导β-catenin的稳定促进食管鳞状细胞癌的发生发展, objectType=article, longId=202443, objectId=640c202443da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=640c202443da, replyNumber=0, likeNumber=76, createdTime=2021-01-03, rootId=0, userName=tongyongming, userId=76d3356, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=640c202443da, moduleTitle=Cell Death Dis：高表达水平DHODH介导β-catenin的稳定促进食管鳞状细胞癌的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=640c202443da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944012, encodeId=fea01944012e0, content=<a href='/topic/show?id=8ef35910fe' target=_blank style='color:#2F92EE;'>#DHODH#</a>, objectTitle=Sci transl med：DHODH，可作为治疗小细胞肺癌的特异性靶点, objectType=article, longId=182648, objectId=d71d1826486d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d71d1826486d, replyNumber=0, likeNumber=69, createdTime=2020-03-31, rootId=0, userName=tongyongming, userId=76d3356, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d71d1826486d, moduleTitle=Sci transl med：DHODH，可作为治疗小细胞肺癌的特异性靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d71d1826486d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DHODH

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#三阴性乳腺癌# #DHODH#

中国药科大学姜虎林教授《Biomaterials》：一种具有GSH消耗和DHODH抑制功能的白蛋白纳米药物有效治疗三阴性乳腺癌

2023-12-29发表于上海

tongyongming (审核中...)

前往app查看评论内容

#DHODH#

Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据

2022-12-18

tongyongming (审核中...)

前往app查看评论内容

#DHODH#

华东理工大学拟以1.5亿元受让DHODH抑制剂相关专利给海南海药

2021-05-29

tongyongming (审核中...)

前往app查看评论内容

#DHODH#

Protein Cell：|李洪林/徐可团队发现靶向宿主DHODH的强效抗新冠病毒候选和临床已有药物

2021-07-06

tongyongming (审核中...)

前往app查看评论内容

#DHODH#

Cell Death Dis：高表达水平DHODH介导β-catenin的稳定促进食管鳞状细胞癌的发生发展

2021-01-03

tongyongming (审核中...)

前往app查看评论内容

#DHODH#

Sci transl med：DHODH，可作为治疗小细胞肺癌的特异性靶点

2020-03-31

科室
- - 订阅+
  - 更多科室
工具
服务